Transmutex, V-Labs, GliaPharm and Deasyl get FIF Funding

Please login or
register
04.07.2022
v labs working with Deutsche Bahn
Fongit, the Fondation Genevoise pour l’Innovation Technologique has announced the latest beneficiaries of the Fongit Innovation Fund (FIF). Four Geneva-based startups have each been awarded a seed loan of CHF 100,000: Transmutex, V-Labs, GliaPharm and Deasyl

The FIF is the instrument for fostering innovation and the scale up of promising companies from the Canton of Geneva at the service of the United Nations (UN) Sustainable Development Goals (SDGs). The FIF is supported by the State of Geneva, the Geneva Chamber of Commerce (CCIG), International Trade Center (ITC) and UN Environment. Last week, four startups have secured FIF support receiving CHF 100’000 each:
 
Transmutex SA is developing a breakthrough nuclear energy process technology, coming from CERN, that will be intrinsically safe, reduce the stockpile of long-lived waste, be resistant to military proliferation, and be cost competitive. Transmutex have partnered with the most respected research centers and industry players in the world to deliver a pilot nuclear plant within a decade.
 
V-Labs SA helps surveyors, contractors and engineers visualize, modify, and acquire geospatial data with centimeter accuracy in the field by using augmented reality glasses. Their efficient hands-free and easy-to-use solution increases performance while reducing costs and safety risks.  
 
GliaPharm SA provides an innovative therapeutic approach targeting glial cells, the ‘support cells’ of neurons, to sustain their function and survival, and enhance brain metabolism in pathological conditions. The company, coming from EPFL and based at Campus Biotech in Geneva, aims to develop new drugs that target glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions impaired by diseases such as Alzheimer.
 
Deasyl SA is aiming to disrupt the Biodiesel market by turning the 2nd generation biodiesel into the fuel of the future and allowing production at local level rather than in large production plants. This startup, which has been already awarded of EUR 2.5M grant by the State Secretariat for Education, Research and Innovation SERI, uses a patented solid catalyst instead of the traditional liquid ones, that greatly reduces the number of harmful substances used to produce biodiesel while at the same time increases efficiency. Deasyl promotes circular economy while producing a positive environmental Impact.

The next deadlines to apply for FIF support are 5 August and 7 October 2022.  Learn more on the Fongit Innovation Fund webpage.

0Comments

Company profiles on startup.ch

Gliapharm SA

Transmutex SA

V-Labs SA

rss